August 4, 2014 | EndyMed, an Israeli medical equipment developer creating equipment based on radio frequency technologies, signed an agreement with Chinese company OHMK Medical Technology for $7 million. OHMK will acquire 47.93 million EndyMed shares, giving OHMK a 37.21 percent stake in the company. OHMK markets EndyMed’s products EndyMed Glow and EndyMed Pro in China. Founded in 2007, EndyMed is a medical technology company specializing in the design, development and sale of energy based aesthetic treatments. The company’s products have been approved by the Food & Drug Administration in the United States and China.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

AI Startup Helps Doctors Analyze Heart Scans
February 08, 2023

AI Monitors High-Speed Conveyor Belts For Defects
February 08, 2023

Israel Hi-Tech Group In Rescue Mission To Turkey
February 08, 2023

Israeli Startup Tests Cancer Treatment With Pharma Giant
February 07, 2023
Facebook comments